Jonathan W. Lischalk
Georgetown University, NYU Langone Health, Long Island University
Papers
10
Total Citations
75
H-Index
4
About
Jonathan W. Lischalk is a radiation oncologist whose research centers on stereotactic body radiation therapy (SBRT) for challenging cancer cases, particularly in the prostate and lung. His major contributions include pioneering SBRT for ultra-central NSCLC recurrences after high-dose conventional radiation, a setting with limited salvage options, and demonstrating the feasibility of SBRT for prostate cancer in patients with inflammatory bowel disease and ultra-large (≥100 cc) glands—populations historically considered high-risk for radiation toxicity. He has also advanced the use of iodinated rectal spacers (SpaceOAR Vue™) to spare the rectum during prostate SBRT, especially in MRI-contraindicated patients. His work on salvage SBRT after cryoablation failures and SBRT boosts for high-risk prostate cancer expands treatment paradigms. With over 70 citations across his top papers, Lischalk’s research is impactful for its focus on expanding SBRT’s reach to complex, undertreated populations. Notable achievements include his 2017 study on ultra-central NSCLC recurrences (32 citations) and his 2021 case report on SpaceOAR Vue™, which addresses a critical gap in prostate radiotherapy.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10